Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 234Carcinoma, Non-Small-Cell Lung 132Breast Neoplasms 121Glioblastoma 88Ovarian Neoplasms 86Carcinoma, Hepatocellular 69Rectal Neoplasms 64Brain Neoplasms 58Lung Neoplasms 55Neoplasm Metastasis 54Neoplasms 52Colonic Neoplasms 50Fallopian Tube Neoplasms 43Glioma 40Carcinoma, Renal Cell 35Gliosarcoma 34Melanoma 26Adenocarcinoma of Lung 26Pancreatic Neoplasms 23Liver Neoplasms 23Uterine Cervical Neoplasms 21Stomach Neoplasms 21Recurrence 21Triple Negative Breast Neoplasms 18Kidney Neoplasms 16Endometrial Neoplasms 16Esophageal Neoplasms 15Astrocytoma 14Carcinoma, Ovarian Epithelial 13Adenocarcinoma, Bronchiolo-Alveolar 13

Interventions

Bevacizumab 2Steroids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Brain Injuries × Bevacizumab × Clear all
NCT05303259 2022-03-31

BRAIN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
204 enrolled

Brain Injuries

NCT04553510 2020-09-17

Treatment of Bevacizumab Followed by Steroid in RN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
86 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Brain Injuries, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡